Exponent INC Form 4 insider transactions
NASDAQ
EXPO
Exponent INCExponent's Group Vice President, Bradley A. James, converted 4,664 vested Restricted Stock Units into common stock and subsequently sold 1,559 shares to cover tax obligations.
NASDAQ
EXPO
Exponent INCExponent Inc.'s President & CEO, Catherine Corrigan, converted vested Restricted Stock Units into common stock and subsequently sold a portion to cover tax obligations.
NASDAQ
EXPO
Exponent INCExponent Group Vice President Maureen T. F. Reitman reported gifting 140 shares of common stock, reducing her direct beneficial ownership to 35,472 shares.
NASDAQ
EXPO
Exponent INCExponent Inc.'s President and CEO, Catherine Corrigan, was granted 28,500 stock options at an exercise price of $70.16, vesting over four years.
NASDAQ
EXPO
Exponent INCExponent Inc.'s EVP & CFO, Richard L. Schlenker Jr., was granted 19,000 stock options at an exercise price of $70.16, vesting over four years.
NASDAQ
EXPO
Exponent INCExponent Inc. CEO Catherine Corrigan exercised stock options and sold a portion of the acquired shares to cover exercise costs and taxes.
NASDAQ
EXPO
Exponent INCExponent Inc.'s EVP & Chief Financial Officer, Richard L. Schlenker Jr., exercised incentive stock options to acquire 4,230 shares of common stock.
NASDAQ
EXPO
Exponent INCExponent Inc.'s VP of Global Offices & Innovation, John Pye, sold a total of 4,000 shares of common stock on February 10, 2026.
NASDAQ
EXPO
Exponent INCExponent Inc.'s President & CEO, Catherine Corrigan, reported exercising stock options and selling a portion of her common stock holdings under a pre-arranged 10b5-1 plan.
NASDAQ
EXPO
Exponent INCExponent Inc.'s President and CEO, Catherine Corrigan, exercised incentive stock options, acquiring 7,872 shares of common stock.
NASDAQ
EXPO
Exponent INCExponent Inc.'s President & CEO, Catherine Corrigan, sold 3,225 shares of common stock after exercising stock options under a Rule 10b5-1 plan.
NASDAQ
EXPO
Exponent INCExponent CEO Catherine Corrigan exercised 5,605 options and sold 4,900 shares under a Rule 10b5-1 plan, boosting direct holdings to 84,134 shares.
NASDAQ
EXPO
Exponent INCExponent Inc.'s President & CEO, Catherine Corrigan, exercised stock options and subsequently sold a portion of the acquired shares to cover exercise costs and taxes.
NASDAQ
EXPO
Exponent INCExponent Inc.'s President and CEO, Catherine Corrigan, exercised stock options and sold a portion of the acquired shares on September 15, 2025.
NASDAQ
EXPO
Exponent INCExponent Inc.'s President & CEO, Catherine Corrigan, exercised stock options and sold a portion of the acquired shares to cover exercise costs and taxes.
NASDAQ
EXPO
Exponent INCExponent Inc. Group Vice President Joseph Sala sold all 1,595 of his directly held common shares for $70.6406 per share.
NASDAQ
EXPO
Exponent INCExponent Inc. Director Carol Lindstrom reported the conversion of vested Restricted Stock Units into common shares and the grant of new RSUs, as detailed in a recent SEC Form 4 filing.
NASDAQ
EXPO
Exponent INCExponent Inc. Director Paul R. Johnston has reported the conversion of 1,525 vested Restricted Stock Units into common stock and the grant of 2,009 new Restricted Stock Units.
NASDAQ
EXPO
Exponent INCExponent Inc. Director Debra Zumwalt reported the conversion of previously vested Restricted Stock Units into common stock and the acquisition of new RSU awards, aligning her interests with shareholders.
NASDAQ
EXPO
Exponent INCForm 4: Exponent Inc. Director Karen Richardson Reports Routine Stock Transactions and New RSU Grant
Exponent Inc. Director Karen A. Richardson has reported the conversion of vested Restricted Stock Units into common stock and the grant of new RSUs, aligning her interests with shareholders.
NASDAQ
EXPO
Exponent INCExponent Inc. Director George H. Brown reported the conversion of previously vested Restricted Stock Units into common stock and the grant of new equity awards, aligning his interests with shareholder value.
NASDAQ
EXPO
Exponent INCJoseph Rakow, Group Vice President at Exponent Inc., has reported the sale of 1,573 shares of common stock, liquidating his direct beneficial ownership in the company.
NASDAQ
EXPO
Exponent INCJohn Pye, Group Vice President at Exponent Inc., sold a total of 2,000 shares of common stock on May 23, 2025, through a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
EXPO
Exponent INCGroup Vice President Bradley A. James of Exponent Inc. reports selling 2,694 shares of common stock at a price of $79.5224 on May 20, 2025.
NASDAQ
EXPO
Exponent INCRichard L. Schlenker Jr., EVP & Chief Financial Officer of Exponent Inc., reports acquisition and disposal of derivative securities (Restricted Stock Units) on March 14, 2025.
NASDAQ
EXPO
Exponent INCGroup Vice President Joseph Sala reports acquiring 7,012 Restricted Stock Units of Exponent Inc. on March 14, 2025, according to a Form 4 filing.
NASDAQ
EXPO
Exponent INCMaureen T.F. Reitman, Group Vice President at Exponent Inc., reports the acquisition of 7,738 Restricted Stock Units on March 14, 2025, according to a Form 4 filing with the SEC.
NASDAQ
EXPO
Exponent INCRichard Reiss, Group Vice President of Exponent Inc., reports the acquisition of 2,032 Restricted Stock Units (RSUs) on March 14, 2025.
NASDAQ
EXPO
Exponent INCGroup Vice President Joseph Rakow reports acquisition of restricted stock units and disposal of common stock.
NASDAQ
EXPO
Exponent INCGroup Vice President John Pye reports acquiring and disposing of restricted stock units in Exponent Inc.